The invention relates to a medicament containing, as an active ingredient, a polymer guanidine derivative or the pharmaceutically acceptable salts of the same, based on a diamine containing oxyalkylene chains between two amino groups. Said guanidine derivative is a product of the polycondensation of a guanidine acid addition salt with a diamine containing polyalkylene chains between two amino groups.
